The Cell Technology group offers a service of development of animal cell based processes suitable for industrial production of biopharmaceutical (e.g. antibody, glycoprotein) in e.g. CHO, HEK293 or NS0 cell-based system in preparation for clinical phase I manufacturing.


  • Extensive experience of process development for biopharmaceutical industry, e.g. CHO, NS0, HEK293
  • Development of fed-batch or perfusion process process suitable for commercial production
  • Process transfer to Contract Manufacturing Organization (CMO) for GMP production, including support to pilot/commercial size
  • Full documentation and traceability
  • Consulting for biopharmaceutical process development and produciton



Since the initiation of this service facility in 2008, numerous services have been delivered by the CETEG, among other: Three fed-batch processes were developed for the production of biopharmaceutical, i.e. monoclonal antibody and glycoproteins. Two processes were successfully transferred to CMO for GMP production in view of manufacturing of clinical material. Material was manufactured for toxicological study in 4 L and 20 L sizes for two processes. 


This website is using cookiesfor statistics and a better user experience

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.